Cargando…

Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling

Rosiglitazone (RGZ), a thiazolidinedione ligand of the peroxisome proliferator-activated receptor (PPAR)-γ, has been recently described as possessing antitumoral properties. We investigated RGZ effect on cell proliferation in two cell line models (SW13 and H295R) of human adrenocortical carcinoma (A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantini, Giulia, Lombardi, Adriana, Piscitelli, Elisabetta, Poli, Giada, Ceni, Elisabetta, Marchiani, Sara, Ercolino, Tonino, Galli, Andrea, Serio, Mario, Mannelli, Massimo, Luconi, Michaela
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491299/ https://www.ncbi.nlm.nih.gov/pubmed/18670617 http://dx.doi.org/10.1155/2008/904041

Ejemplares similares

2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2015)

Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression
por: Cantini, Giulia, et al.
Publicado: (2021)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
por: Cantini, Giulia, et al.
Publicado: (2021)

New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer
por: Salvianti, Francesca, et al.
Publicado: (2017)

Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study
por: Cantini, Giulia, et al.
Publicado: (2020)

Metformin as a new anti-cancer drug in adrenocortical carcinoma
por: Poli, Giada, et al.
Publicado: (2016)

The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model
por: Armignacco, Roberta, et al.
Publicado: (2019)

Antineoplastic effects of rosiglitazone and PPARγ transactivation in neuroblastoma cells
por: Cellai, I, et al.
Publicado: (2006)

Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment
por: Fei, L., et al.
Publicado: (2023)

In vivo effects of rosiglitazone in a human neuroblastoma xenograft
por: Cellai, I, et al.
Publicado: (2010)

Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma
por: Luconi, Michaela, et al.
Publicado: (2023)

Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience
por: De Filpo, G., et al.
Publicado: (2021)

Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation
por: Hantel, Constanze, et al.
Publicado: (2016)

Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia
por: Provenzano, Aldesia, et al.
Publicado: (2022)

Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma
por: De Filpo, Giuseppina, et al.
Publicado: (2020)

Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane
por: Cantini, Giulia, et al.
Publicado: (2023)

IGF2 role in adrenocortical carcinoma biology
por: Pereira, Sofia S., et al.
Publicado: (2019)

Oxidative Stress in the Healthy and Wounded Hepatocyte: A Cellular Organelles Perspective
por: Mello, Tommaso, et al.
Publicado: (2016)

Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer Model
por: Durfort, Tiphanie, et al.
Publicado: (2012)

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
por: Li, Heming, et al.
Publicado: (2017)

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis
por: Beneit, N., et al.
Publicado: (2016)

Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses
por: Malaguarnera, Roberta, et al.
Publicado: (2015)

Interaction between IGF-IR and ER Induced by E2 and IGF-I
por: Yu, Zhenghong, et al.
Publicado: (2013)

Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
por: Parenti, Gabriele, et al.
Publicado: (2012)

SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation
por: De Filpo, Giuseppina, et al.
Publicado: (2020)

Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators
por: Turvey, Samuel J., et al.
Publicado: (2022)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021)

IGF2 Promotes Growth of Adrenocortical Carcinoma Cells, but Its Overexpression Does Not Modify Phenotypic and Molecular Features of Adrenocortical Carcinoma
por: Guillaud-Bataille, Marine, et al.
Publicado: (2014)

IGF-IR determines the fates of BCR/ABL leukemia
por: Xie, Jingjing, et al.
Publicado: (2015)

IGF-IR Targeted Therapy: Past, Present and Future
por: Janssen, Joseph A. M. J. L., et al.
Publicado: (2014)

The Role of Metabolic Changes in Shaping the Fate of Cancer-Associated Adipose Stem Cells
por: Cantini, Giulia, et al.
Publicado: (2020)

IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling
por: Yoneyama, Yosuke, et al.
Publicado: (2018)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

The novel IGF-IR/Akt–dependent anticancer activities of glucosamine
por: Song, Ki-Hoon, et al.
Publicado: (2014)

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer
por: Mauro, Loredana, et al.
Publicado: (2015)

IGF-IR: a new prognostic biomarker for human glioblastoma
por: Maris, C, et al.
Publicado: (2015)

Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors
por: Perge, Pál, et al.
Publicado: (2017)

Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
por: Xu, Lieyu, et al.
Publicado: (2016)

Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in the Adipose Stem Cell
por: Baglioni, Silvana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_e21a8i0vi092f0tvf3po65l8i4